Small-Cell Lung Cancer - Pipeline Review, H1 2020

Market: Pharmaceuticals and Healthcare

Global, 1397 pages report, published by Global Markets Direct

Report ThumbnailJune-2020
Small-Cell Lung Cancer - Pipeline Review, H1 2020

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Pipeline Review, H1 2020, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer. SCLC is the most aggressive form of lung cancer. It usually starts in the breathing tubes (

Read More
  • List of Figures
  • Number of Products under Development for Small-Cell Lung Cancer, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020
  • Number of Products by Top 10 Targets, H1 2020
  • Number of Products by Stage and Top 10 Targets, H1 2020
  • Number of Products by Top 10 Mechanism of Actions, H1 2020
  • Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
  • Number of Products by Top 10 Routes of Administra
Read More
  • List of Tables
  • Number of Products under Development for Small-Cell Lung Cancer, H1 2020
  • Number of Products under Development by Companies, H1 2020
  • Number of Products under Development by Universities/Institutes, H1 2020
  • Products under Development by Companies, H1 2020
  • Products under Development by Universities/Institutes, H1 2020
  • Number of Products by Stage and Target, H1 2020
  • Number of Products by Stage and Mechanism of Action, H1 2020
  • Number of Products by Stage and Route of Administration, H1
Read More
  • Table of Contents
  • Introduction
  • Small-Cell Lung Cancer - Overview
  • Small-Cell Lung Cancer - Therapeutics Development
  • Small-Cell Lung Cancer - Therapeutics Assessment
  • Small-Cell Lung Cancer - Companies Involved in Therapeutics Development
  • Small-Cell Lung Cancer - Drug Profiles
  • Small-Cell Lung Cancer - Dormant Projects
  • Small-Cell Lung Cancer - Discontinued Products
  • Small-Cell Lung Cancer - Product Development Milestones
  • Appendix
Read More

Please select a license type

Share

Related Products

Global Markets DirectSmall-Cell Lung Cancer - Pipeline Review, H1 2020Product ThumbnailSmall-Cell Lung Cancer - Pipeline Review, H1 2020, Industry ReportProduct #: 1219733
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2020 Global Market Analyst. All Rights Reserved